All Articles

Price threshold analysis of biomarker surveillance for hepatocellular carcinoma in Australia

Surveillance for patients at risk of hepatocellular carcinoma: how to improve its cost-effectiveness and expand the role of multidisciplinary tumor board?

Pathophysiology of liver cirrhosis and risk correlation between immune status and the pathogenesis of hepatocellular carcinoma

Hepatocellular carcinoma recurrence after liver transplantation: risk factors, targeted surveillance and management options

Barriers to surveillance for hepatocellular cancer among patients with chronic liver disease -providers' perspectives

MRI for screening and surveillance for hepatocellular cancer in NAFLD and NASH

Ultrasonography in surveillance for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease

Challenges and barriers in hepatocellular carcinoma (HCC) surveillance for patients with non-alcoholic fatty liver disease (NAFLD)

Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease patients

Hepatocellular carcinoma in Hepatitis B and Human Immunodeficiency Virus coinfection in Africa: a focus on surveillance

Sonography in surveillance for HCC in NAFLD patients

Cholangiocarcinoma: early detection and screening in high-risk population

Hepatocellular carcinoma surveillance: current practice and future directions

Extrahepatic cancer risk after liver transplantation for hepatocellular carcinoma: incidence, risk and prevention

Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology

Guideline for stratified screening and surveillance in patients with high risk of primary liver cancer (2020)

Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI

Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response